DUBLIN--(BUSINESS WIRE)--The "Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors pipeline products by developmental stage, product type, molecule type, and administration route.
Scope
-
The report provides a snapshot of the pipeline development for
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors
-
The report covers pipeline activity across the complete product
development cycle i.e. clinical, pre-clinical and discovery stages for
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors
- The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development, route of administration, and molecule
type for Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors
-
The report also covers the dormant and discontinued pipeline projects
related to the Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors
- Ionis Pharmaceutical
- H3 Biomedicine Inc
- Daiichi Sankyo Inc.
- Blueprint Medicines Corp.
- Incyte Corporation
- Genosco
- AstraZeneca
- Eli Lilly
Key Topics Covered
1. Report Introduction
2. Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2018 Overview
3. Pipeline Therapeutics
-
An Overview of the Market
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/fjtw6t/fibroblast_growth?w=4
